Medicine & Life Sciences
Cohort Studies
100%
Comorbidity
90%
Asthma
72%
Interrupted Time Series Analysis
64%
Antithyroid Agents
63%
Cardiovascular Diseases
61%
Population
59%
Coronavirus
58%
Republic of Korea
55%
Diclofenac
54%
Angiotensin-Converting Enzyme Inhibitors
46%
Propylthiouracil
44%
Scotland
38%
England
36%
Observational Studies
36%
Meta-Analysis
34%
Systematic Reviews
34%
Regression Analysis
30%
Peripheral Arterial Disease
29%
Netherlands
28%
Hyperthyroidism
28%
Pregnancy
28%
Mortality
27%
Myocardial Ischemia
23%
Thorax
22%
Human Influenza
21%
Denmark
21%
Child
20%
Hyperlipidemias
20%
Contraindications
19%
Hypertension
19%
Odds Ratio
17%
Confidence Intervals
15%
Angiotensin Receptor Antagonists
15%
Multimorbidity
14%
Cerebrovascular Disorders
13%
Olfaction Disorders
13%
Calibration
12%
Chronic Obstructive Pulmonary Disease
11%
Pneumonia
11%
Carbimazole
10%
Hospitalization
10%
Respiratory Hypersensitivity
10%
Primary Health Care
10%
Statistics
10%
Enzyme Therapy
9%
Methimazole
9%
Numbers Needed To Treat
8%
Dyspnea
8%
Adult Respiratory Distress Syndrome
8%
Enalapril
8%
Safety
7%
Bradykinin
7%
Spain
7%
Databases
7%
Hypoxia
7%
Electronic Health Records
6%
Famotidine
6%
Heart Diseases
6%
Enoxaparin
6%
Uncertainty
6%
Primary Prevention
6%
Demography
6%
MEDLINE
5%
Bronchiolitis
5%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5%
Heart Neoplasms
5%
Neurodevelopmental Disorders
5%
Case-Control Studies
5%
Therapeutics
5%
Social Sciences
comorbidity
56%
mortality
39%
cardiovascular disease
27%
performance
21%
statistics
7%
incident
5%
discrimination
5%
death
5%